← Open Payments lookup

ELI ANDERSON: Open Payments

NPI 1053342634 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,129 in 47 payments from 10 companies in 2025. Trend: 2023 $1,345 · 2024 $913 · 2025 $1,129

Food & beverage: $1,129
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$283
ABBVIE INC.7$249
Neurocrine BioSciences, Inc.7$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$163
Otsuka America Pharmaceutical, Inc.3$71
Alkermes, Inc.3$70
E.R. Squibb & Sons, L.L.C.2$48
Janssen Pharmaceuticals, Inc2$44
Takeda Pharmaceuticals U.S.A., Inc.1$18
Axsome Therapeutics, Inc.1$13

Products named: UZEDY, VRAYLAR, INGREZZA, CAPLYTA, ARISTADA, COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.